Thalassaemia

AT Taher, DJ Weatherall, MD Cappellini - The Lancet, 2018 - thelancet.com
Inherited haemoglobin disorders, including thalassaemia and sickle-cell disease, are the
most common monogenic diseases worldwide. Several clinical forms of α-thalassaemia and …

Iron chelators in treatment of iron overload

S Entezari, SM Haghi, N Norouzkhani… - Journal of …, 2022 - Wiley Online Library
Patients suffering from iron overload can experience serious complications. In such patients,
various organs, such as endocrine glands and liver, can be damaged. Although iron is a …

[HTML][HTML] Challenges of blood transfusions in β-thalassemia

FT Shah, F Sayani, S Trompeter, E Drasar, A Piga - Blood reviews, 2019 - Elsevier
Patients with β-thalassemia major (BTM) require regular blood transfusions, supported by
appropriate iron chelation therapy (ICT), throughout their life. β-thalassemia is a global …

β-Thalassemias

AT Taher, KM Musallam… - New England Journal of …, 2021 - Mass Medical Soc
β-Thalassemias Defective synthesis of the β-globin chain causes recessively inherited
disorders characterized by inadequate hemoglobin production and chronic anemia …

[PDF][PDF] Inherited haemoglobin disorders: an increasing global health problem

DJ Weatherall, JB Clegg - Bulletin of the World Health …, 2001 - SciELO Public Health
Pese a los grandes avances de nuestros conocimientos sobre la patología molecular, la
fisiopatología y el control y manejo de las hemoglobinopatías hereditarias, miles de …

Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload

LJ Anderson, S Holden, B Davis, E Prescott… - European heart …, 2001 - academic.oup.com
Aims To develop and validate a non-invasive method for measuring myocardial iron in order
to allow diagnosis and treatment before overt cardiomyopathy and failure develops …

Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine

C Borgna-Pignatti, S Rugolotto, P De Stefano… - …, 2004 - haematologica.org
BACKGROUND AND OBJECTIVES: Seven Italian centers reported data on survival, causes
of death and appearance of complications in patients with thalassemia major. The …

Cardiovascular function and treatment in β-thalassemia major: a consensus statement from the American Heart Association

DJ Pennell, JE Udelson, AE Arai, B Bozkurt… - Circulation, 2013 - Am Heart Assoc
This aim of this statement is to report an expert consensus on the diagnosis and treatment of
cardiac dysfunction in β-thalassemia major (TM). This consensus statement does not cover …

Iron-chelating therapy and the treatment of thalassemia

NF Olivieri, GM Brittenham - … Journal of the American Society of …, 1997 - ashpublications.org
(BM) expansion, permit normal development throughout childhood, and extend survival. 1 In
parallel, transfusions re- Early studies of the use of neocytes, or young RBCs, sult in a …

Thalassaemia

DR Higgs, JD Engel, G Stamatoyannopoulos - The lancet, 2012 - thelancet.com
Thalassaemia is one of the most common genetic diseases worldwide, with at least 60 000
severely affected individuals born every year. Individuals originating from tropical and …